BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 12802915)

  • 41. Characterization of granulocyte colony-stimulating factor receptor expressed on human lymphocytes.
    Morikawa K; Morikawa S; Nakamura M; Miyawaki T
    Br J Haematol; 2002 Jul; 118(1):296-304. PubMed ID: 12100165
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Prolonged administration of all-trans retinoic acid in combination with intensive chemotherapy and G-CSF for adult acute myelogenous leukemia: single-centre pilot study in different risk groups.
    Bassan R; Chiodini B; Lerede T; Giussani U; Oldani E; Buelli M; Rossi A; Viero P; Rambaldi A; Barbui T
    Hematol J; 2002; 3(4):193-200. PubMed ID: 12189565
    [TBL] [Abstract][Full Text] [Related]  

  • 43. High remission rate, short remission duration in patients with refractory anemia with excess blasts (RAEB) in transformation (RAEB-t) given acute myelogenous leukemia (AML)-type chemotherapy in combination with granulocyte-CSF (G-CSF).
    Estey EH; Kantarjian HM; O'Brien S; Kornblau S; Andreeff M; Beran M; Pierce S; Keating M
    Cytokines Mol Ther; 1995 Mar; 1(1):21-8. PubMed ID: 9384660
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Expression of G-CSFR IV isoform in adult acute myeloid leukemia and its clinical significance].
    Wu Y; Chen YY; Chen YZ
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2014 Aug; 22(4):899-902. PubMed ID: 25130800
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Timed-sequential chemotherapy with concomitant granulocyte colony-stimulating factor for newly diagnosed de novo acute myelogenous leukemia.
    He XY; Pohlman B; Lichtin A; Rybicki L; Kalaycio M
    Leukemia; 2003 Jun; 17(6):1078-84. PubMed ID: 12764371
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Expression and prognostic value of hemopoietic cytokine receptors in acute myeloid leukemia (AML): implications for future therapeutical strategies.
    Graf M; Hecht K; Reif S; Pelka-Fleischer R; Pfister K; Schmetzer H
    Eur J Haematol; 2004 Feb; 72(2):89-106. PubMed ID: 14962246
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Granulocyte colony stimulating factor increases drug resistance of leukaemic blast cells to daunorubicin.
    Márkász L; Hajas G; Kiss A; Lontay B; Rajnavölgyi E; Erdodi F; Oláh E
    Pathol Oncol Res; 2008 Sep; 14(3):285-92. PubMed ID: 18493867
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Effects of mast cell growth factor on acute myeloid leukemia cells in vitro: effects of combinations with other cytokines.
    Budel LM; Delwel R; van Buitenen C; Hoogerbrugge H; Löwenberg B
    Leukemia; 1993 Mar; 7(3):426-34. PubMed ID: 7680401
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Defects of granulopoiesis in patients with severe congenital neutropenia.
    Nakamura K; Kobayashi M; Konishi N; Kawaguchi H; Miyagawa S; Sato T; Katoh O; Ueda K
    Hiroshima J Med Sci; 2002 Sep; 51(3):63-74. PubMed ID: 12422946
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Effect of the chimeric soluble granulocyte colony-stimulating factor receptor on the proliferation of leukemic blast cells from patients with acute myeloblastic leukemia.
    Asano Y; Yokoyama T; Shibata S; Kobayashi S; Shimoda K; Nakashima H; Okamura S; Niho Y
    Cancer Res; 1997 Aug; 57(16):3395-7. PubMed ID: 9270003
    [TBL] [Abstract][Full Text] [Related]  

  • 51. High-dose cytarabine, idarubicin, and granulocyte colony-stimulating factor remission induction therapy for previously untreated de novo and secondary adult acute myeloid leukemia.
    Baer MR; Christiansen NP; Frankel SR; Brunetto VL; Mrózek K; Bloomfield CD; Herzig GP
    Semin Oncol; 1993 Dec; 20(6 Suppl 8):6-12. PubMed ID: 7507264
    [TBL] [Abstract][Full Text] [Related]  

  • 52. High-frequency granuloid colony-forming ability of G-CSF receptor possessing CD34 antigen positive human umbilical cord blood hematopoietic progenitors.
    Shimoda K; Okamura S; Harada N; Kubota A; Iwasaki H; Ohno Y; Niho Y
    Exp Hematol; 1995 Mar; 23(3):226-8. PubMed ID: 7533100
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Granulocyte colony-stimulating factor receptor mediated cell growth and differentiation.
    Li J; Sartorelli AC
    Oncol Res; 1995; 7(12):591-601. PubMed ID: 8704276
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Expression of granulocyte colony-stimulating factor receptor correlates with prognosis in oral and mesopharyngeal carcinoma.
    Tsuzuki H; Fujieda S; Sunaga H; Noda I; Saito H
    Cancer Res; 1998 Feb; 58(4):794-800. PubMed ID: 9485037
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Flow cytometric analysis of G-CSF receptors on normal white cells and leukemic cells.
    Yamane T; Im T; Tatsumi N; Okuda K
    Osaka City Med J; 1993 Jun; 39(1):11-23. PubMed ID: 7694217
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Expression of granulocyte-colony-stimulating factor and its receptor in human Ewing sarcoma cells and patient tumor specimens: potential consequences of granulocyte-colony-stimulating factor administration.
    Morales-Arias J; Meyers PA; Bolontrade MF; Rodriguez N; Zhou Z; Reddy K; Chou AJ; Koshkina NV; Kleinerman ES
    Cancer; 2007 Oct; 110(7):1568-77. PubMed ID: 17694551
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Value of different modalities of granulocyte-macrophage colony-stimulating factor applied during or after induction therapy of acute myeloid leukemia.
    Löwenberg B; Boogaerts MA; Daenen SM; Verhoef GE; Hagenbeek A; Vellenga E; Ossenkoppele GJ; Huijgens PC; Verdonck LF; van der Lelie J; Wielenga JJ; Schouten HC; Gmür J; Gratwohl A; Hess U; Fey MF; van Putten WL
    J Clin Oncol; 1997 Dec; 15(12):3496-506. PubMed ID: 9396403
    [TBL] [Abstract][Full Text] [Related]  

  • 58. CD7 expression in acute myeloid leukemia.
    Del Poeta G; Stasi R; Venditti A; Cox C; Aronica G; Masi M; Bruno A; Simone MD; Buccisano F; Papa G
    Leuk Lymphoma; 1995 Mar; 17(1-2):111-9. PubMed ID: 7539657
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Granulocyte colony-stimulating receptor promotes beta1-integrin-mediated adhesion and invasion of bladder cancer cells.
    Chakraborty A; White SM; Guha S
    Urology; 2006 Jul; 68(1):208-13. PubMed ID: 16844458
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Immunophenotyping is an independent factor for risk stratification in AML.
    Repp R; Schaekel U; Helm G; Thiede C; Soucek S; Pascheberg U; Wandt H; Aulitzky W; Bodenstein H; Sonnen R; Link H; Ehninger G; Gramatzki M;
    Cytometry B Clin Cytom; 2003 May; 53(1):11-9. PubMed ID: 12717686
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.